The Cardiac Mechanical Assist Device Program at Cedars-Sinai Heart Institute provides complete state-of-the-art mechanical support for patients with end-stage heart failure. Heart disease is the number one killer in the United States for both men and women, many of whom die while awaiting heart transplantation. The Mechanical Assist Device Program helps bridge the time between needing and receiving a heart transplant for patients who might otherwise not survive until a donor heart becomes available to them.
Cedars-Sinai has a long history of pioneering heart surgery. In 1978 Cedars-Sinai became the second program in the United States to implant the St. Jude valve, which eliminates the need for a living donor. Today the Cardiac Mechanical Assist Device Program continues in this tradition by offering the most up-to-date, innovative cardiac technology.
Heart failure may affect either or both sides (biventricular) of the heart. The Cardiac Mechanical Assist Device Program can treat these areas of the heart with mechanical support that is designed to be a temporary bridge to transplantation. These devices can even inhibit organ deterioration while awaiting a donor heart.
